Search clinical trials for: Losartan and Amlodipine

Total 272550 results

Midas Pharma GmbH

Completed

Drug-drug-interaction Study of Ramipril, Amlodipine and Atorvastatin

Healthy Volunteers

Jordan
Royal Perth Hospital
The University of Western Australia

Recruiting

Sympathoinhibition as a Preferred Second Line Treatment of Obesity Related Hypertension (OHT)

Hypertension | Obesity

Australia
Yaounde Central Hospital

Completed

Evaluation of Losartan and Perindopril in Blacks Type 2 Diabetics Patients (CARE-PLP)

Type 2 Diabetes Mellitus

Cameroon
Roxane Laboratories

Completed

Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg /25 mg Tablet Under Fed Conditions

Hypertension

United States
Sir Mortimer B. Davis - Jewish General Hospital
Merck Frosst Canada Ltd.

Terminated

Losartan Versus Hydrochlorothiazide in Reversing Remodeling of Small Arteries in Pre-Hypertensive Pre-Diabetic Subjects

Pre-diabetes | Pre-hypertension

Canada
Boehringer Ingelheim

Completed

Telmisartan Compared to Losartan + Hydrochlorothiazide in Patients With Mild-to-moderate Essential Hypertension

Hypertension
Kurume University

Completed

Morning Hypertension and Preminent Therapy Study

Hypertension

Japan
Juntendo University
Japan Heart Foundation

Completed

Azelnidipine Anti-Coronary Atherosclerotic Trial in Hypertensive Patients by Serial Volumetric IVUS Analysis(ALPS-J)

Hypertension | Coronary Atherosclerosis

Japan
Boehringer Ingelheim

Completed

Bioequivalence Study of Telmisartan Between Telmisartan 80 mg/Amlodipine 5 mg FDC Tablet and Telmisartan 80 mg Tab and Amlodipine 5 mg Tab Concomitant Use

Healthy

Japan
Boehringer Ingelheim

Withdrawn

Comparison of the Medication Adherence of Patients Treated With Telmisartan/Hydrochlorothiazide or Telmisartan/Amlodipine Fixed Dose Combination (FDC) Versus Double-pill Combination Therapy in Real-world Japanese Therapeutic Practice

Hypertension

Japan
Fox Chase Cancer Center
National Cancer Institute (NCI)

Recruiting

PHL Treatment in Pancreatic Cancer

Pancreatic Ductal Adenocarcinoma

United States
Torrent Pharmaceuticals Limited

Completed

Bioequivalence Study of Losartan Potassium and Hydrochlorothiazide (100 mg / 25 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Hyzaar® (100 mg / 25 mg Tablet) [Reference Formulation, Merck & Co., Inc., USA] in Healthy Human Volunteers Under Fed Conditions

Healthy

India
Centre for Chronic Disease Control, India
All India Institute of Medical Sciences, New Delhi; Imperial College London

Recruiting

Treatment Optimisation for Blood Pressure With Single-Pill Combinations in India (TOPSPIN)

Primary Hypertension

India
Shin Poong Pharmaceutical Co. Ltd.

Completed

Evaluate the Efficacy and Safety of SPC1001 and Monotherapy in Patients With Essential Hypertension (SP-CAP-002)

Hypertension | Essential Hypertension

Korea, Republic of
Shin Poong Pharmaceutical Co. Ltd.

Completed

Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential Hypertension

Essential Hypertension

Korea, Republic of
Chong Kun Dang Pharmaceutical

Unknown

Efficacy and Safety of TELMINUVO to Stage 2 Hypertension

Hypertension

Korea, Republic of
XueQing Yu

Recruiting

Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes (IPAD)

Diabetes Mellitus, Type 2 | Prehypertension | Blood Pressure | Cardiovascular Risk Factor | Adverse Event

China
Pfenex, Inc

Completed

A Comparison of PF708 and Forteo in Osteoporosis Patients

Osteoporosis

United States
Novartis Pharmaceuticals

Completed

Effect of the Fixed Dose Combination Amlodipine/Valsartan on Central Aortic Blood Pressure in Uncontrolled Essential Hypertension With Amlodipine 5 mg (EXPLOR)

Hypertension

France
Organon and Co

Completed

A 52 Week Study to Evaluate the Effects of Losartan With or Without HCTZ on Plasma Glucose, Metabolic Parameters, Blood Pressure in Hypertensive Patients With Metabolic Syndrome (0954A-331)

Hypertension | Metabolic Disorder
Istituto Auxologico Italiano
Italian Society of Hypertension; Italian Society of General Practitioners; Yghea

Terminated

Prevention of Diabetes and Hypertension (PHIDIAS)

Hypertension | Diabetes Mellitus

Italy
Organon and Co

Completed

Evaluation of the Antihypertensive Effect of Hyzaar(R) and Cognitive Function of Hypertensive Patients (0954A-322)

Hypertension
Roxane Laboratories

Completed

Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg/25 mg Tablet Under Fasted Conditions

Hypertension

United States
National Taiwan University Hospital

Completed

Kallikrein-kinin (KKS) and Renin-angiotensin-aldosterone System (RAAS) in Primary Aldosteronism

Hyperaldosteronism

Taiwan
Merck Sharp & Dohme LLC

Completed

Antihypertensive Response to Losartan and Genetic Polymorphisms

Hypertension
University of Roma La Sapienza

Unknown

Once-daily Fixed Combination of Three Antihypertensive Drugs (ONE&ONLY)

Arterial Hypertension

Italy
Amsterdam UMC, location VUmc

Completed

Renohemodynamic Effects of Combined empagliflOzin and LosARtan (RECOLAR)

Diabetes Mellitus, Type 2 | Diabetic Kidney Disease

Netherlands
Teva Pharmaceuticals USA

Completed

Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Non-Fasting Conditions

Healthy

United States
University Magna Graecia

Completed

Inhibitors of Angiotensin II in Proteinuric Mesangioproliferative Glomerulonephritis

IGA Glomerulonephritis

Italy
Pfizer

Completed

Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Adults 60 Through 64 Years of Age

Pneumococcal Infections

United States
Servier Russia

Completed

Description of the Effectiveness, Safety, Tolerability and Adherence to Amlodipine/Atorvastatin/Perindopril Single Pill Combination Treatment in Patients With Arterial Hypertension and Dyslipidemia (TARGET) (TARGET)

Arterial Hypertension | HTN

Russian Federation
Northwestern University
National Heart, Lung, and Blood Institute (NHLBI); American Society for Transplantation

Withdrawn

Mechanism of Hypertension Treatments in Liver Transplant Recipients (BLOCK LTR-HTN)

High Blood Pressure | Liver Transplant | Renal Function Abnormal

United States
Seoul National University Hospital
Dong-A Pharmaceutical Co., Ltd.

Completed

Efficacy Study of PDE-5 Inhibitor and Calcium Channel Inhibitor for the Treatment of Secondary Raynaud Phenomenon

Raynaud Phenomenon

Korea, Republic of
Novartis Pharmaceuticals
Baker Heart and Diabetes Institute

Completed

Valsartan Intensified Primary Care Reduction of Blood Pressure Study (VIPER-BP)

Hypertension

United States, Australia
Kyushu University

Completed

Combination Pill of Losartan Potassium and Hydrochlorothiazide for Improvement of Medication Compliance Trial (COMFORT)

Hypertension

Japan
Merck Sharp & Dohme LLC

Completed

A Study to Investigate the Magnitude and Duration of Response of MK0954 Compared to Placebo in Patients With Hypertension (0954-021)(COMPLETED)

Hypertension
US Department of Veterans Affairs

Terminated

VA NEPHRON-D: Diabetes iN Nephropathy Study (VA NEPHRON-D)

Type 2 Diabetes | Nephropathy | Kidney Disease

United States, Puerto Rico
Boehringer Ingelheim

Completed

PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM)

Hypertension

United States
IRCCS Policlinico S. Matteo
Merck Sharp & Dohme LLC; Menarini Group

Unknown

Nebivolol Versus Losartan Versus Nebivolol+Losartan Against Aortic Root Dilation in Genotyped Marfan Patients (MaNeLo)

Marfan Syndrome

Italy
Chong Kun Dang Pharmaceutical

Completed

Efficacy and Safety of CKD-828 to Stage 2 Hypertension

Hypertension

Korea, Republic of
Third Military Medical University

Completed

A Randomized, Double-Blind, Active Control Trial Comparing Effects of Telmisartan, Candesartan and Amlodipine, Alone or Plus Metformin, on Non-Diabetic, Obese Hypertensive Patients (HOT-ACME)

Hypertension | Obesity

China
Ludwig-Maximilians - University of Munich
Maastricht University Medical Center; UMC Utrecht; University of Oxford; University...

Terminated

Effects of Amlodipine and Other Blood Pressure Lowering Agents on Microvascular Function (TREAT-SVDs)

Cerebral Small Vessel Diseases

Netherlands, Germany, United Kingdom
University Hospital for Infectious Diseases, Croatia

Completed

Effect of Extra Virgin Olive Oil on Atherosclerosis Biomarkers in HIV-infected Patients (EVOO_HIV)

HIV Infections | Atherosclerosis | HIV

Croatia
Takeda

Completed

Study to Evaluate the Efficacy and Safety of Combined Administration of TAK-536CCB and Hydrochlorothiazide in Patients With Grade I or II Essential Hypertension.

Grade I or II Essential Hypertension

Japan
Novartis Pharmaceuticals

Withdrawn

Study of the Efficacy and Safety of LCZ696 Alone and in Combination With Amlodipine in Patients With Hypertension

Hypertension
James A. Tumlin, MD
Nelson Kopyt, MD

Recruiting

Safety and Efficacy of Two Year of RAAS Alone or in Combination With Spironolactone Therapy (MRA-ACE)

Renal Insufficiency, Chronic | Diabetic Nephropathy Type 2

United States
Novartis

Completed

Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Valsartan Alone

Hypertension

Switzerland, Germany
Novartis

Completed

Effectiveness of a Valsartan Based vs an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy

Hypertension

Switzerland, Germany
Chong Kun Dang Pharmaceutical

Completed

CKD-828 S-Amlodipine Non-Responder Trial

Hypertension

Korea, Republic of
Bayer

Completed

Controlled Release Nifedipine and Valsartan Combination Therapy in Patients With Essential Hypertension

Hypertension

Japan

3

Subscribe